Milestone Journey

Akums has consistently set benchmarks in pharmaceutical manufacturing, evolving into a Leading CDMO with an commitment to innovation, quality, and excellence. Our journey is marked by significant milestones, from pioneering advanced formulations to expanding our global footprint. Over the years, we have built a strong foundation based on research-driven solutions, regulatory expertise, and cutting-edge technology. Each achievement reflects our dedication to transforming healthcare and delivering superior pharmaceutical solutions. As we continue to grow, we remain committed to shaping the future of healthcare with trust, integrity, and innovation.

Incorporation

2004-2007

Company Incorporation

Every requisite for establishing a manufacturing set-up was done from scratch.

Incorporation of the Company. Established the first plant for oral dosage in Haridwar, Uttarakhand.

Established a dedicated manufacturing site for oral liquid dosage.

Expansion

2007-2010

Expansion

Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals.

Dedicated a facility for hormones, cosmetics, and dermatology.

Innovations

2010-2012

Innovations

Innovated bi-layered sustained release tablets for the first time.

Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities.

Market Expansion

2012-2015

Market Expansion

Innovated tablet-in-tablet sustained release tablets for the first time. Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities. Expanded into the African market.

Expanded into the Asian market. Established a research and development laboratory in Mumbai, Maharashtra to venture into the regulated market.

Certifications & Investments

2015-2019

Certifications & Investments

Maxcure Nutravedics Limited received US-NSF certification.

Investment by Ruby Quadria Capital Investment Holdings Pte. Ltd. in Akums, becoming a minority shareholder.

European Accreditation

2019-2022

European Accreditation

Started Akums Lifesciences Limited to venture into APIs. Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited.

Two manufacturing plants accredited with European Union Good Manufacturing Practices, qualifying for exports to European markets. Acquisition of facilities in Haridwar and Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited.

Acquisitions & Mergers

2022-2023

Acquisitions & Mergers

Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited. Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited.

IPO Listing

2023-2024

IPO Listing

Akums achieved a major milestone by going public, reflecting its significant growth and solidifying its leadership in the pharmaceutical industry. The IPO marks a new era for Akums, enabling further expansion and innovation on a global scale.

  • 2004
  • 2007
  • 2010
  • 2012
  • 2015
  • 2019
  • 2022
  • 2023

BUILD OR ENHANCE YOUR CURRENT SUPPLY WITH AKUMS

Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.




    Manage Your Cookie Preferences